Focus on multiple myeloma

被引：133

作者：

Mitsiades, CS ^{[1
]}

Mitsiades, N

Munshi, NC

Anderson, KC

机构：

[1] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol,Jerome Lipper Multiple Myeloma Ctr, Boston, MA 02115 USA

[2] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA

来源：

CANCER CELL | 2004年 / 6卷 / 05期

关键词：

D O I：

10.1016/j.ccr.2004.10.020

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：439 / 444

页数：6

共 64 条

[11] The enigma of ectopic expression of FGFR3 in multiple myeloma:: a critical initiating event or just a target for mutational activation during tumor progression [J].

Chesi, M ;

Bergsagel, PL ;

Kuehl, WM .

CURRENT OPINION IN HEMATOLOGY, 2002, 9 (04) :288-293

[12] High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma [J].

Child, JA ;

Morgan, GJ ;

Davies, FE ;

Owen, RG ;

Bell, SE ;

Hawkins, K ;

Brown, J ;

Drayson, MT ;

Selby, PJ .

NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (19) :1875-1883

[13] THALIDOMIDE IS AN INHIBITOR OF ANGIOGENESIS [J].

DAMATO, RJ ;

LOUGHNAN, MS ;

FLYNN, E ;

FOLKMAN, J .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (09) :4082-4085

[14] Thalidomide and immunomodulatory derivatives augment natural killer cell cytotoxicity in multiple myeloma [J].

Davies, FE ;

Raje, N ;

Hideshima, T ;

Lentzsch, S ;

Young, G ;

Tai, YT ;

Lin, B ;

Podar, K ;

Gupta, D ;

Chauhan, D ;

Treon, SP ;

Richardson, PG ;

Schlossman, RL ;

Morgan, GJ ;

Muller, GW ;

Stirling, DI ;

Anderson, KC .

BLOOD, 2001, 98 (01) :210-216

[15] Insights into the multistep transformation of MGUS to myeloma using microarray expression analysis [J].

Davies, FE ;

Dring, AM ;

Li, C ;

Rawstron, AC ;

Shammas, MA ;

O'Connor, SM ;

Fenton, JAL ;

Hideshima, T ;

Chauhan, D ;

Tai, IT ;

Robinson, E ;

Auclair, D ;

Rees, K ;

Gonzalez, D ;

Ashcroft, AJ ;

Dasgupta, R ;

Mitsiades, C ;

Mitsiades, N ;

Chen, LB ;

Wong, WH ;

Munshi, NC ;

Morgan, GJ ;

Anderson, KC .

BLOOD, 2003, 102 (13) :4504-4511

[16]

Fonseca Rafael, 2004, Cancer Research, V64, P1546, DOI 10.1158/0008-5472.CAN-03-2876

[17] Macrophage inflammatory protein-1α is an osteoclastogenic factor in myeloma that is independent of receptor activator of nuclear factor κB ligand [J].

Han, JH ;

Choi, SJ ;

Kurihara, N ;

Koide, M ;

Oba, Y ;

Roodman, GD .

BLOOD, 2001, 97 (11) :3349-3353

[18] The ubiquitin system [J].

Hershko, A ;

Ciechanover, A .

ANNUAL REVIEW OF BIOCHEMISTRY, 1998, 67 :425-479

[19]

Heslop Helen E, 2003, Hematology Am Soc Hematol Educ Program, P331

[20]

Hideshima T, 2001, CANCER RES, V61, P3071

← 1 2 3 4 5 6 7 →